ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SPARC is a key mediator of TGF-β-induced renal cancer metastasis

Bao, Ji-Ming; Dang, Qiang; Lin, Chun-Jung; Lo, U-Ging; Feldkoren, Boris; Dang, Andrew; Hernandez, Elizabeth; Li, Fei; Panwar, Vandana; Lee, Cheng-Fan; Cen, Jun-Jie; Guan, Bing; Margulis, Vitaly; Kapur, Payal; Brekken, Rolf A.; Luo, Jun-Hang*; Hsieh, Jer-Tsong*; Tan, Wan-Long*南方医科大学; 中山大学; 1
Journal of Cellular Physiology2021-3DOI: 10.1002/jcp.29975
27被引4阅读
引用收藏
分享

摘要

Aberrant expression of transforming growth factor-beta 1 (TGF-beta 1) is associated with renal cell carcinoma (RCC) progression by inducing cancer metastasis. However, the downstream effector(s) in TGF-beta signaling pathway is not fully characterized. In the present study, the elevation of secreted protein acidic and rich in cysteine (SPARC) as a TGF-beta regulated gene in RCC was identified by applying differentially expressed gene analysis and microarray analysis, we further confirmed this result in several RCC cell lines. Clinically, the expression of these two genes is positively correlated in RCC patient specimens. Furthermore, elevated SPARC expression is found in all the subtypes of RCC and positively correlated with the RCC stage and grade. In contrast, SPARC expression is inversely correlated with overall and disease-free survival of patients with RCC, suggesting SPARC as a potent prognostic marker of RCC patient survival. Knocking down SPARC significantly inhibits RCC cell invasion and metastasis both in vitro and in vivo. Similarly, in vitro cell invasion can be diminished by using a specific monoclonal antibody. Mechanistically, SPARC activates protein kinase B (AKT) pathway leading to elevated expression of matrix metalloproteinase-2 that can facilitate RCC invasion. Altogether, our data support that SPARC is a critical role of TGF-beta signaling network underlying RCC progression and a potential therapeutic target as well as a prognostic marker.

学科与关键词

关键词
MMP-2renal cancer metastasisSnailSPARCTGF-beta 1
相关
加载中…
  • Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
    Bao, Ji-Ming*; Zhi, Xi; Yuan, Hao-Yu; Chen, Tao-Yi; Chen, Ming-Kun; Zhou, Jun-Hao; Xue, Kang-Yi; Yang, Jian-Kun*; Liu, Cun-Dong*Translational Cancer Research, 2023, 12(3): 572-584.
  • MicroRNA-19b-1 Up-Regulation Promotes Cell Invasion and Metastasis in Renal Cell Carcinoma
    Hu, Qiyi; Wang, Zhu; Lai, Yulin; Deng, Qiong; Zhang, Jianwen; Liang, Hui; Wei, Anyang*JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37(7): 3803-3810.
  • Expression and Cytoplasmic Localization of SAM68 Is a Significant and Independent Prognostic Marker for Renal Cell Carcinoma
    Zhang Zhiling; Li Jun; Zheng Haiqing; Yu Chunping; Chen Jin; Liu Zhuowei; Li Manzhi; Zeng Musheng; Zhou Fangjian; Song Libing*Cancer Epidemiology Biomarkers and Prevention, 2009, 18(10): 2685-2693.被引 22
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular Physiology
发表日期
2021-03
卷期
第 236 卷, 第 3 期
页码
1926-1938
DOI
10.1002/jcp.29975
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
American Cancer Society [133186-PF-19-087-01-CSM]; Health Commission of Guangdong Province [A2019513]; China Scholarship Council [201508440279]; National Cancer Institute [1P30 CA142543]

作者

  • B

    Bao, Ji-Ming (第一作者)

    southern med univ

  • D

    Dang, Qiang

    southern med univ

查看全部 18 位作者收起作者
  • L

    Lin, Chun-Jung

  • L

    Lo, U-Ging

  • F

    Feldkoren, Boris

  • D

    Dang, Andrew

  • H

    Hernandez, Elizabeth

  • L

    Li, Fei

    southern med univ

  • P

    Panwar, Vandana

  • L

    Lee, Cheng-Fan

  • C

    Cen, Jun-Jie

    1 · sun yat sen univ

  • G

    Guan, Bing

  • M

    Margulis, Vitaly

  • K

    Kapur, Payal

  • B

    Brekken, Rolf A.

  • L

    Luo, Jun-Hang (通讯)

    1 · sun yat sen univ

  • H

    Hsieh, Jer-Tsong (通讯)

  • T

    Tan, Wan-Long (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417